Here are three things to know.
1. ProteiOS is a novel allograft-derived growth factor which provides several osteoinductive, angiogenic and mitogenic growth factors in a lyophilized powder form.
2. It can be used with any scaffold FDA-approved for use with bone marrow aspirate.
3. ProteiOS growth factor is Biologica’s first orthopedic and neurosurgery offering. The company launched ProteiOS in a targeted release in 2017 Q4; it is now available across the U.S.
More articles on biologics:
4 things to know about Datum Orthobiologics, a newly formed company
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
